192 related articles for article (PubMed ID: 29907642)
21. WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERT
Zhang K; Guo Y; Wang X; Zhao H; Ji Z; Cheng C; Li L; Fang Y; Xu D; Zhu HH; Gao WQ
Cancer Res; 2017 May; 77(9):2534-2547. PubMed ID: 28209613
[TBL] [Abstract][Full Text] [Related]
22. Telomerase reverse transcriptase mediates EMT through NF-κB signaling in tongue squamous cell carcinoma.
Wu Y; Bian C; Zhen C; Liu L; Lin Z; Nisar MF; Wang M; Bartsch JW; Huang E; Ji P; Yang L; Yu Y; Yang J; Jiang X; Zhong JL
Oncotarget; 2017 Oct; 8(49):85492-85503. PubMed ID: 29156735
[TBL] [Abstract][Full Text] [Related]
23. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations.
Isenmann S; Cakouros D; Zannettino A; Shi S; Gronthos S
J Bone Miner Res; 2007 Jun; 22(6):897-906. PubMed ID: 17352650
[TBL] [Abstract][Full Text] [Related]
24. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A
Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825
[TBL] [Abstract][Full Text] [Related]
25. TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes.
Liu F; Kong X; Lv L; Gao J
Cancer Lett; 2015 Apr; 359(2):288-98. PubMed ID: 25633840
[TBL] [Abstract][Full Text] [Related]
26. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
Lamb R; Ozsvari B; Bonuccelli G; Smith DL; Pestell RG; Martinez-Outschoorn UE; Clarke RB; Sotgia F; Lisanti MP
Oncotarget; 2015 Sep; 6(26):21892-905. PubMed ID: 26323205
[TBL] [Abstract][Full Text] [Related]
27. Effect of Pioglitazone and Cetuximab on Colon Cancer Stem-like Cell (CCSLCs) Properties.
Alamdar N; Farivar S; Baghaei K; Hamidieh AA; Soltaninejad H; Aghdaei HA; Zali M; Saltanatpour Z
Curr Stem Cell Res Ther; 2024 Jan; ():. PubMed ID: 38303523
[TBL] [Abstract][Full Text] [Related]
28. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.
Marcucci F; Ghezzi P; Rumio C
Mol Cancer; 2017 Jan; 16(1):3. PubMed ID: 28137290
[TBL] [Abstract][Full Text] [Related]
29. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
30. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Wu XQ; Huang C; He X; Tian YY; Zhou DX; He Y; Liu XH; Li J
Cell Signal; 2013 Dec; 25(12):2462-8. PubMed ID: 23993966
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
32. B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells.
Zhi Y; Mou Z; Chen J; He Y; Dong H; Fu X; Wu Y
PLoS One; 2015; 10(8):e0135528. PubMed ID: 26284927
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL.
Yu CC; Chang YC
Toxicol Appl Pharmacol; 2013 Feb; 266(3):459-69. PubMed ID: 23219715
[TBL] [Abstract][Full Text] [Related]
34. Cardiac Stem Cell Secretome Protects Cardiomyocytes from Hypoxic Injury Partly via Monocyte Chemotactic Protein-1-Dependent Mechanism.
Park CY; Choi SC; Kim JH; Choi JH; Joo HJ; Hong SJ; Lim DS
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231894
[TBL] [Abstract][Full Text] [Related]
35. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
36. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
37. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
[TBL] [Abstract][Full Text] [Related]
38. The non-reverse transcriptase activity of the human telomerase reverse transcriptase promotes tumor progression (review).
Qin Y; Guo H; Tang B; Yang SM
Int J Oncol; 2014 Aug; 45(2):525-31. PubMed ID: 24888567
[TBL] [Abstract][Full Text] [Related]
39. Pomegranate Extract Alters Breast Cancer Stem Cell Properties in Association with Inhibition of Epithelial-to-Mesenchymal Transition.
Nallanthighal S; Elmaliki KM; Reliene R
Nutr Cancer; 2017 Oct; 69(7):1088-1098. PubMed ID: 28976208
[TBL] [Abstract][Full Text] [Related]
40. Shorter telomeres and high telomerase activity correlate with a highly aggressive phenotype in breast cancer cell lines.
Ceja-Rangel HA; Sánchez-Suárez P; Castellanos-Juárez E; Peñaroja-Flores R; Arenas-Aranda DJ; Gariglio P; Benítez-Bribiesca L
Tumour Biol; 2016 Sep; 37(9):11917-11926. PubMed ID: 27072825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
